The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models.

vobramitamab duocarmazine (MGC018) - MacroGenics

http://www.ncbi.nlm.nih.gov/pubmed/41507126

Barbara Cafferata; Barbara De Giovanni; Chiara Brignole; Daniela Segalerba; Eleonora Ciampi; Fabio Pastorino; Gaia Rolandi; Giovanna Bianchi; Matilde Balbi; Mirco Ponzoni; Silvia Ravera; Valerio Gaetano Vellone

Jan 9, 2026